Clin2
NCT06454149Worth exploringRecruiting

Study of gastric MALT lymphoma

Gastric MALT Lymphoma

Part of Cancer, Digestive system clinical trials.

This study is looking at people with a rare stomach lymphoma (MALT lymphoma) or people with other stomach conditions. It aims to understand more about the disease and track outcomes over time.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
18 years to 75 years
Study type
Observational

Who can take part

  • You have a stomach condition being checked by endoscopy (a camera test of your stomach).
  • Either you were just diagnosed with gastric MALT lymphoma, or you have chronic gastritis, stomach polyps, or no symptoms and had a screening endoscopy.
  • You have not had cancer in the past (including stomach cancer).
  • You have not taken antibiotics or probiotics in the last 4 weeks.
  • You do not have any uncontrolled long-term health problems (like diabetes or heart disease that isn't well managed).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07376330Not yet recruiting
Study of tissue samples in malt lymphoma

This trial studies tissue samples from people with MALT lymphoma (a type of low-grade lymphoma) to learn more about its biology. It aims to improve understanding of the disease, which could help future treatments.

Milan
NCT07144657Not yet recruiting· Phase 2
Antibiotics for early stomach lymphoma

This study tests whether antibiotics alone can treat early-stage stomach lymphoma that is not linked to H. pylori infection. The goal is to see if antibiotics can control the disease and avoid more intensive treatments.

Taipei, None Selected
NCT07705308Not yet recruiting· Phase 2
Low-dose radiation plus targeted pill for MALT lymphoma

This study tests a combination of a low dose of radiation and an oral targeted drug (orelabrutinib) for people with early-stage MALT lymphoma. The goal is to see if adjusting the treatment based on your response can be effective and reduce side effects.

Shanghai, Shanghai Municipality
NCT07139418Recruiting
Studying lymph nodes around the stomach in cancer surgery

This trial studies the importance of checking lymph nodes in the fatty tissue around the stomach during stomach cancer surgery. It helps doctors understand if examining these specific areas can improve treatment decisions.

Hangzhou, Zhejiang
NCT05956847Recruiting
Studying DNA fragments in stomach cancer tissue

This trial looks at tiny pieces of DNA found outside cells in stomach tissue to better understand how gastric (stomach) cancer starts and progresses. It may help future patients by improving how doctors study stomach cancer from biopsy and surgical samples.

Xi'an, Shaanxi
NCT06370143Recruiting
Health information study to understand and prevent stomach cancer

This study collects health information from people at different stages of stomach cancer risk, including those with precancerous changes, healthy individuals, and those with early stomach cancer. The goal is to better understand and prevent stomach cancer.

Basking Ridge, New Jersey

Hear when a new Gastric MALT Lymphoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.